Otoprotective effect of recombinant erythropoietin in a model of newborn hypoxic-ischemic encephalopathy
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, vol.77, no.5, pp.739-746, 2013 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 77 Issue: 5
- Publication Date: 2013
- Doi Number: 10.1016/j.ijporl.2013.01.029
- Journal Name: INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.739-746
- Keywords: Hypoxic-ischemic encephalopathy, Hearing loss, Erythropoietin
- Dokuz Eylül University Affiliated: Yes
Abstract
Objective: The aim of this study is to test the hypotheses that central auditory pathology as well as inner ear pathology is contributing mechanisms to observed hypoxic-ischemic encephalopathy (HIE) induced hearing loss and that recombinant erythropoietin (rhEPO) will reduce this cellular pathology and attenuate hearing loss.